The difficulty patients face in obtaining medicine stems directly from a supply chain that has failed to develop on par with the broader health sector, Dr Shah Abdulla Mahir, the managing director of State Pharmaceutical and Medical Supply Corporation Limited, or State Pharma, said.
Addressing the structural deficiencies that prevent the public from readily accessing prescribed medications remains the company's primary mandate, Shah noted, adding that the state-run firm commenced fulfilling prescriptions in April and has since delivered to over 1,000 citizens.
Procuring these medications involves navigating complex bureaucratic hurdles, stringent temperature-regulated storage requirements, and international sourcing difficulties. A lack of institutional uniformity further complicates the system, requiring urgent standardisation of billing codes and reconciliation of varied marketplace brands.
"From the moment a prescription is issued to a patient, the required medication must be readily accessible," Shah remarked. Internal research revealed that only 25 per cent of medications utilised nationwide are registered with the State Trading Organisation. Consequently, the company is partnering with private entities to stabilise retail prices and implementing preemptive procurement to build robust stockpiles.
Shah noted that the crisis reflects a developmental imbalance between advanced clinical capabilities and a lagging logistical backbone. "In reality, this issue emerged because certain structural systems and logistical protocols remained unorganised as the broader healthcare system of the Maldives underwent rapid development," Shah remarked, pledging that visible improvements will appear within six months.